PERRIGO ISRAEL FDA Approval ANDA 076872

ANDA 076872

PERRIGO ISRAEL

FDA Drug Application

Application #076872

Documents

Letter2004-12-30

Application Sponsors

ANDA 076872PERRIGO ISRAEL

Marketing Status

Prescription001

Application Products

001OINTMENT;TOPICAL0.05%0HALOBETASOL PROPIONATEHALOBETASOL PROPIONATE

FDA Submissions

ORIG1AP2004-12-16

TE Codes

001PrescriptionAB

CDER Filings

PERRIGO ISRAEL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 76872
            [companyName] => PERRIGO ISRAEL
            [docInserts] => ["",""]
            [products] => [{"drugName":"HALOBETASOL PROPIONATE","activeIngredients":"HALOBETASOL PROPIONATE","strength":"0.05%","dosageForm":"OINTMENT;TOPICAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"HALOBETASOL PROPIONATE","submission":"HALOBETASOL PROPIONATE","actionType":"0.05%","submissionClassification":"OINTMENT;TOPICAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.